Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity

被引:47
|
作者
Hidaka, M [1 ]
Fujita, K [1 ]
Ogikubo, T [1 ]
Yamasaki, K [1 ]
Iwakiri, T [1 ]
Okumura, M [1 ]
Kodama, H [1 ]
Arimori, K [1 ]
机构
[1] Miyazaki Med Coll Hosp, Dept Pharm, Kiyotake, Miyazaki 8891692, Japan
关键词
D O I
10.1124/dmd.32.6.581
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There has been very limited information on the capacities of tropical fruits to inhibit human cytochrome P450 3A (CYP3A) activity. Thus, the inhibitory effects of tropical fruits on midazolam 1'-hydroxylase activity of CYP3A in human liver microsomes were evaluated. Eight tropical fruits such as common papaw, dragon fruit, kiwi fruit, mango, passion fruit, pomegranate, rambutan, and star fruit were tested. We also examined the inhibition of CYP3A activity by grapefruit ( white) and Valencia orange as controls. The juice of star fruit showed the most potent inhibition of CYP3A. The addition of a star fruit juice (5.0%, v/v) resulted in the almost complete inhibition of midazolam 1'-hydroxylase activity (residual activity of 0.1%). In the case of grapefruit, the residual activity was 14.7%. The inhibition depended on the amount of fruit juice added to the incubation mixture (0.2-6.0%, v/v). The elongation of the preincubation period of a juice from star fruit (1.25 or 2.5%, v/v) with the microsomal fraction did not alter the CYP3A inhibition, suggesting that the star fruit did not contain a mechanism-based inhibitor. Thus, we discovered filtered extracts of star fruit juice to be inhibitors of human CYP3A activity in vitro.
引用
收藏
页码:581 / 583
页数:3
相关论文
共 50 条
  • [21] Enhancement of the Oral Availability of Cabazitaxel Using the Cytochrome P450 3A (CYP3A) Inhibitor Ritonavir in Mice
    Loos, Nancy H. C.
    Martins, Margarida L. F.
    de Jong, Danielle
    Lebre, Maria C.
    Tibben, Matthijs
    Beijnen, Jos H.
    Schinkel, Alfred H.
    MOLECULAR PHARMACEUTICS, 2023, : 2477 - 2489
  • [22] Isolation of cytochrome P450 3A (CYP3A) inhibitors from Hyuganatsu, Citrus tamurana Hort.
    Shinzo Hosoi
    Eri Shimizu
    Noriyuki Usami
    Ikuo Yamamoto
    Kazuhiko Arimori
    Manabu Okumura
    Muneaki Hidaka
    Mitsuko Yamada
    Akiyo Sakushima
    Journal of Natural Medicines, 2006, 60 : 240 - 242
  • [23] Inhibition of human liver cytochrome P450 by star fruit juice
    Zhang, Jiang-Wei
    Liu, Yong
    Cheng, Jie
    Li, Wei
    Ma, Hong
    Liu, Hong-Tao
    Sun, Jie
    Wang, Li-Ming
    He, Yu-Qi
    Wang, Yun
    Wang, Zheng-Tao
    Yang, Ling
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2007, 10 (04): : 496 - 503
  • [24] Cytochrome P450 3A expression and activity in the human small intestine
    Yang, JS
    Tucker, GT
    Rostami-Hodjegan, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (04) : 391 - 391
  • [25] Sources of variability in ketoconazole inhibition of human cytochrome P450 3A in vitro
    Greenblatt, David J.
    Venkatakrishnan, Karthik
    Harmatz, Jerold S.
    Parent, Sarah J.
    von Moltke, Lisa L.
    XENOBIOTICA, 2010, 40 (10) : 713 - 720
  • [26] Cloning and tissue distribution of a novel human cytochrome P450 of the CYP3A subfamily, CYP3A43
    Westlind, A
    Malmebo, S
    Johansson, I
    Otter, C
    Andersson, TB
    Ingelman-Sundberg, M
    Oscarson, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (05) : 1349 - 1355
  • [27] Mechanism-based inactivation of cytochrome P450 3A (CYP3A) by HIV protease inhibitors (PI's)
    Ernest, CS
    Hall, SD
    Jones, DR
    DRUG METABOLISM REVIEWS, 2003, 35 : 170 - 170
  • [28] Risperidone and cytochrome P450 3A
    deLeon, J
    Bork, J
    JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (10) : 450 - 450
  • [29] Tissue distribution of cytochrome P450 3A (CYP3A) in brushtail possums (Trichosurus vulpecula) exposed to Eucalyptus terpenes
    Sorensen, Jennifer S.
    Forbey, Kristian C.
    Tanquay, Robert L.
    McLeod, Bernie
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2007, 145 (02): : 194 - 201
  • [30] Cytochrome P450 3A and their regulation
    Burk, O
    Wojnowski, L
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (01) : 105 - 124